Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-08T08:02:30.348Z Has data issue: false hasContentIssue false

Can vocal process granuloma location forecast the efficacy of anti-reflux treatment?

Published online by Cambridge University Press:  09 February 2022

J Ding
Affiliation:
Department of Surgery, Yiwu Central Hospital, Yiwu city, China
Z Lou*
Affiliation:
Department of Otorhinolaryngology, Yiwu Central Hospital, Yiwu city, China
*
Author for correspondence: Dr Z Lou, Department of Otorhinolaryngology, Yiwu Central Hospital, 699 Jiangdong road, Yiwu 322000, China E-mail: louzhengcai@163.com
Rights & Permissions [Opens in a new window]

Abstract

Objective

The objective of this study was to evaluate the efficacy of anti-reflux therapy on the idiopathic vocal process granulomas.

Method

This was a prospective case series study. The patients with vocal process granulomas who met the inclusion criteria were analysed. Proton pump inhibitors and vocal hygiene education were conducted for 8–20 weeks.

Results

Of the 16 patients with vocal process granulomas, 5 (31.25 per cent) patients achieved complete remission. The complete remission rate of granulomas was not significantly related to age (p = 1.000), sex (p = 0.296), side (p = 0.299), position (p = 0.100), endoscopic morphology (p = 0.263) or proton pump inhibitor treatment course (p = 0.543) but was significantly associated with granuloma location (p = 0.001) and granuloma size (p = 0.012).

Conclusion

Granulomas in the vocal cord and the margin of the vocal process had an excellent response to proton pump inhibitors, but granulomas on the surface of vocal process and arytenoid cartilage body had little response to proton pump inhibitors. The prolonged period of proton pump inhibitor treatment did not increase the complete remission rate of vocal process granulomas.

Information

Type
Main Article
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED
Figure 0

Fig. 1. Endoscopic images showing position clarity for (a) vocal process type, (b) arytenoid cartilage body type and (c) associated area type. Red arrows indicate arytenoid cartilage body and blue arrows indicate the vocal process.

Figure 1

Fig. 2. Endoscopic images showing location clarity for (a) medial type, (b) surface type and (c) mixed type.

Figure 2

Fig. 3. Endoscopic images showing morphology clarity for (a) ulceration type, (b) cyst type and (c) granulation type.

Figure 3

Table 1. Patient profiles

Figure 4

Table 2. Univariate analysis of prognostic factors of complete remission of vocal process granulomas

Figure 5

Fig. 4. Endoscopic images from a 67-year-old male. (a) Granuloma in the vocal process, (b) 2 weeks post-proton pump inhibitor treatment, (c) 4 weeks post-proton pump inhibitor treatment, (d) 6 weeks post-proton pump inhibitor treatment, (e) 9 weeks post-proton pump inhibitor treatment, (f) 11 weeks post-proton pump inhibitor treatment, (g) 14 weeks post-proton pump inhibitor treatment and (h) 12 months post-proton pump inhibitor treatment.

Figure 6

Fig. 5. Endoscopic images from a 56-year-old female. (a) Granuloma in the arytenoid cartilage body, (b) 1 week post-proton pump inhibitor treatment, (c) 3 weeks post-proton pump inhibitor treatment, (d) 7 weeks post-proton pump inhibitor treatment, (e) 13 weeks post-proton pump inhibitor treatment and (f) 18 weeks post-proton pump inhibitor treatment.

Figure 7

Fig. 6. Endoscopic images from a 56-year-old male. (a) Granuloma showed granulation type of arytenoid cartilage body, (b) 1 week post-proton pump inhibitor treatment, (c) 2 weeks post-proton pump inhibitor treatment, (d) 14 weeks post-proton pump inhibitor treatment, (e) 16 weeks post-proton pump inhibitor treatment, (f) 18 weeks post-proton pump inhibitor treatment, (g) 20 weeks post-proton pump inhibitor treatment and (h) 22 weeks post-proton pump inhibitor treatment.